DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Zhou C, Wu YL, Chen G. et al.
BEYOND: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study of First-Line Carboplatin/Paclitaxel Plus Bevacizumab or Placebo in Chinese Patients With Advanced or Recurrent Nonsquamous Non-Small-Cell Lung Cancer.
J Clin Oncol 2015;
33: 2197-2204
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.